home / stock / avdl / avdl news


AVDL News and Press, Avadel Pharmaceuticals plc From 07/05/22

Stock Information

Company Name: Avadel Pharmaceuticals plc
Stock Symbol: AVDL
Market: NASDAQ
Website: avadel.com

Menu

AVDL AVDL Quote AVDL Short AVDL News AVDL Articles AVDL Message Board
Get AVDL Alerts

News, Short Squeeze, Breakout and More Instantly...

AVDL - LXRX, AVDL and HHS among mid-day movers

Gainers: Rubicon Technology ( RBCN ) +68% . Faraday Future Intelligent Electric ( FFIE ) +65% . Ra Medical Systems ( RMED ) +61% . Xilio Therapeutics ( XLO ) +35% . Maris-Tech ( MTEK ) +35% . Lexicon Pharmaceuticals ( LXRX ...

AVDL - Avadel rises 18% as it expects tentative approval for sleep disorder drug; expects final approval by June 2023

Avadel Pharmaceuticals ( NASDAQ: AVDL ) is trading 18% higher after the company said it expects to receive tentative approval from the U.S. FDA of its therapy FT218 to treat narcolepsy. The company said it was exploring every available pathway to accelerate th...

AVDL - Avadel Pharmaceuticals Provides Corporate Update

Pursuing strategies to accelerate final approval of FT218 NDA Optimizing cost structure to fund strategic priorities and extend cash runway Continuing key activities to accelerate launch timing of FT218, targeting multi-billion-dollar narcolepsy market opportunit...

AVDL - Avadel: Further Delay, But Some Light At The End Of The Tunnel

AVDL's FT218 is going to get delayed further over a patent issue. However, there's a goalpost in sight now, and the date is June 2023. The company is cash-strapped. For further details see: Avadel: Further Delay, But Some Light At The End Of The Tunnel

AVDL - Jazz initiated Buy at UBS on underappreciated potential of cannabidiol drug

UBS has launched its coverage on Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy rating and a $194 per share target, arguing that investors have underestimated the growth prospects of Ireland-based pharma’s cannabidiol drug, Epidiolex. Jazz (JAZZ) recorded ~6% growth of Epidiolex net pro...

AVDL - Jazz Pharmaceuticals: Strong Launch Of Xywav In Idiopathic Hypersomnia

Jazz Pharmaceuticals missed first quarter revenue estimates, but management raised the full-year guidance. The launch of Xywav in idiopathic hypersomnia looks strong, and has driven the best quarter for the oxybate franchise since mid-2020. Business development activity picked up ...

AVDL - Asana, JOANN, Talkspace among premarket losers' pack

JOANN (JOAN) -17% on Q1 earnings release. Boqii Holding (BQ) -10%. Asana (ASAN) -9% on Q1 earnings release. Avadel Pharmaceuticals (AVDL) -6% is collaborating with the American Academy of Sleep Medicine Foundation, to support its 2022 Young Investigators Research...

AVDL - Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2022 Young Investigators Research Forum

DUBLIN, Ireland, June 03, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it entered into an exclusive collaboration with the American Academy of Sleep Medicine (AASM) ...

AVDL - Avadel Pharmaceuticals reports insider transactions from Director, CEO & CFO

Avadel Pharmaceuticals (NASDAQ:AVDL) reported 10K shares acquired by Director Palczuk Linda for $1.6/share while Director Ende Eric J purchased 15K shares for $2.45/share. Director Thornton Peter J. purchased 50K shares for $1.69/share. CEO Divis Gregory J and CFO Mchugh Thomas S. acquir...

AVDL - How to Make Money With Penny Stocks in June, 3 Tips 

3 Tips for Making Money With Penny Stocks Next Month If you’re thinking about buying and selling penny stocks in June, you need to know what you’re doing. There are a lot of things that can go wrong, and if you’re not careful, you could end up losing a lot of money....

Previous 10 Next 10